Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Adagio Medical Holdings (ADGM) Invested Capital (2023 - 2026)

Adagio Medical Holdings has reported Invested Capital over the past 4 years, most recently at $5.7 million for Q1 2026.

  • Quarterly Invested Capital fell 53.83% to $5.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $5.7 million through Mar 2026, down 53.83% year-over-year, with the annual reading at $12.4 million for FY2025, 65.54% down from the prior year.
  • Invested Capital was $5.7 million for Q1 2026 at Adagio Medical Holdings, down from $12.4 million in the prior quarter.
  • Over five years, Invested Capital peaked at $90.3 million in Q3 2024 and troughed at -$140.5 million in Q2 2024.
  • The 4-year median for Invested Capital is $5.7 million (2026), against an average of -$30.3 million.
  • Year-over-year, Invested Capital skyrocketed 173.12% in 2024 and then tumbled 101.45% in 2025.
  • A 4-year view of Invested Capital shows it stood at -$93.8 million in 2023, then soared by 138.39% to $36.0 million in 2024, then plummeted by 65.54% to $12.4 million in 2025, then plummeted by 53.84% to $5.7 million in 2026.
  • Per Business Quant, the three most recent readings for ADGM's Invested Capital are $5.7 million (Q1 2026), $12.4 million (Q4 2025), and -$1.3 million (Q3 2025).